Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

New drug offers hope for treatment of aggressive T-PLL leukemia

New drug offers hope for treatment of aggressive T-PLL leukemia

Penn researchers provide new insights into how Notch drives growth of B-cell cancers

Penn researchers provide new insights into how Notch drives growth of B-cell cancers

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Amid for-profit surge, rural hospice has offered free care for 40 years

Amid for-profit surge, rural hospice has offered free care for 40 years

New CAR-T cell therapy offers effective option for certain blood cancer patients

New CAR-T cell therapy offers effective option for certain blood cancer patients

TGen project to develop standard operating procedures for single-cell RNA sequencing

TGen project to develop standard operating procedures for single-cell RNA sequencing

Arsenic trioxide could be powerful therapy to extend lives of certain glioblastoma patients

Arsenic trioxide could be powerful therapy to extend lives of certain glioblastoma patients

Scientists receive critical funding to study treatments for three deadly cancers

Scientists receive critical funding to study treatments for three deadly cancers

Cascade of costs could push new gene therapy above $1 million per patient

Cascade of costs could push new gene therapy above $1 million per patient

Powering up fat cells could help acute myeloid leukemia patients

Powering up fat cells could help acute myeloid leukemia patients

Vaccinated pediatric cancer patients just as likely as unvaccinated peers to develop flu

Vaccinated pediatric cancer patients just as likely as unvaccinated peers to develop flu

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Research finds higher rates of cancer in world's ‘better’ countries

Research finds higher rates of cancer in world's ‘better’ countries

FDA approved drug found to have anti-cancer activity against previously unknown targets

FDA approved drug found to have anti-cancer activity against previously unknown targets

BU professor receives $792,000 grant to study about aggressiveness of T-ALL

BU professor receives $792,000 grant to study about aggressiveness of T-ALL

Newly discovered compound causes cancer cell death, whilst sparing healthy cells

Newly discovered compound causes cancer cell death, whilst sparing healthy cells

New treatment approach makes cancer cells commit suicide while sparing healthy cells

New treatment approach makes cancer cells commit suicide while sparing healthy cells